跳至主要内容
临床试验/NCT01623219
NCT01623219撤回不适用

Community-Based Telemedicine to Reduce Risk to Georgia Veterans With PTSD

Emory University0 个研究点开始时间: 2012年3月最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
主要终点
CAPS-Clinician Administered PTSD Scale

研究概览

简要总结

The investigator proposes to examine treatment for Posttraumatic Stress Disorder for Veterans who served in Iraq and Afghanistan provided through telemedicine which connects patients to doctors in different locations using the internet. In this study, Veterans will receive prolonged exposure therapy (PE). This treatment has been shown to be effective in reducing PTSD symptoms. For this study 9 weekly 90 minute sessions will be given over a period of up to 3 months. The first 2 sessions of each treatment will involve education, rational and treatment preparation. Sessions 3-9 will consist of recounting the traumatic event out loud and repeatedly. The purpose of this study is to determine if this treatment is effective when given through telehealth. To this end, the investigators propose to enroll up to 20 individuals who will access the investigators services through the GA telehealth network who has hundreds of telehealth sites across the state of Georgia. Patients will go to these sites to access the investigators therapists using GA telehealth equipment. The investigators hypothesize that PE delivered remotely through telemedicine will work to reduce the symptoms of PTSD.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Participants must meet DSM-IV criteria for PTSD due to exposure to a trauma while serving in Operation Iraqi Freedom, Operation Enduring Freedom-Afghanistan, and/or Operation New Dawn.
  • Patients must be literate in English.
  • Patients must be medically healthy or medically stable such that the stress of the therapy is not contraindicated.
  • Participants must comprehend his or her role in treatment and the risks involved in order to be entered.

排除标准

  • Patients with a history of mania, schizophrenia, or other psychoses
  • Patients with prominent suicidal ideation
  • Patients with current alcohol or drug dependence
  • Patients with special medical conditions such as pregnancy, renal insufficiency, those with various chronic diseases or a history of significant head injury

结局指标

主要结局

CAPS-Clinician Administered PTSD Scale

时间窗: Post-Treatment (10 weeks)

次要结局

  • BDI-II-Beck Depression Inventory-II(Post-Treatment (10 weeks))
  • PTSD Symptom Scale Self Report-PSS-SR(Post-Treatment (10 weeks))
  • Credibility/Expectancy Questionnaire-CEQ(post treatment (10 weeks))
  • Client Satisfaction Questionnaire-CSQ(post treatment (10 weeks))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Barbara O. Rothbaum, PhD

Professor in Psychiatry and Associate Vice Chair of Clinical Research

Emory University

相似试验